{
    "clinical_study": {
        "@rank": "75547", 
        "arm_group": {
            "arm_group_label": "BM-MNC injection", 
            "arm_group_type": "Experimental", 
            "description": "Injection of autologous bone marrow-derived mononuclear cells"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether autologous bone marrow-derived stem cells\n      are effective in the treatment of lower extremity ischemia."
        }, 
        "brief_title": "Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Lower Extremity Ischemia", 
            "Leg Ulcer", 
            "Peripheral Vascular Disease", 
            "Diabetic Foot", 
            "Gangrene"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Gangrene", 
                "Ischemia", 
                "Leg Ulcer", 
                "Ulcer", 
                "Vascular Diseases", 
                "Peripheral Vascular Diseases", 
                "Peripheral Arterial Disease", 
                "Diabetic Foot"
            ]
        }, 
        "detailed_description": {
            "textblock": "Critical limb ischemia (CLI) is a debilitating and disabling disease. Symptoms include pain\n      at rest, loss of tissue integrity, distal amputations and have a major impact on the quality\n      of life. Despite recent advances in surgical vascular procedures, a large number of patients\n      (approximately 40%) are not eligible for these revascularization procedures. New strategies\n      for revascularization need to be explored. Besides, in some cases results of such\n      interventions do not give desirable effect, search of new methods of treatment therefore is\n      necessary. Recent evidence indicates that bone marrow-derived mononuclear cells (BM-MNC) are\n      a potential new therapeutic target."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Critical lower limb ischemia, defined as ischemic pain at rest and / or the presence\n             of minor tissue loss, with the possibility of healing.\n\n          -  Failure of conventional medical treatment and attempts to open or percutaneous\n             revascularization before, with an observation period of two months after the last\n             attempt at revascularization.\n\n          -  Patients considered at high risk for new revascularization procedure by at least two\n             independent observers.\n\n        Exclusion Criteria:\n\n          -  Expected life span less than six months\n\n          -  Large tissue loss in the ischemic limb indicating the need for limb amputation in the\n             short term.\n\n          -  Evidence of osteomyelitis in the ischemic extremity.\n\n          -  Current or previous history of neoplasia.\n\n          -  Unstable angina, recent stroke or other medical condition that contraindicate\n             anesthesia for bone marrow aspiration.\n\n          -  Proliferative retinopathy.\n\n          -  Debilitating disease with a life span less than one year.\n\n          -  Myelofibrosis, myelodysplasia or other diseases that affect the bone marrow.\n\n          -  Use of alcohol in excess of twice-daily doses or history of illicit drug use.\n\n          -  Need for continuous high doses of drug therapy with steroids (more than 7.5 mg/day).\n\n          -  Posivity for HIV or syphilis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01903044", 
            "org_study_id": "ICMI_ 404732/2012-7"
        }, 
        "intervention": {
            "arm_group_label": "BM-MNC injection", 
            "description": "BM-MNC cells will be injected in aliquots of 1 ml at multiple regions of the leg muscles", 
            "intervention_name": "BM-MNC injection", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lowe extremity ischemia", 
            "Bone marrow", 
            "Neoangiogenesis"
        ], 
        "lastchanged_date": "July 16, 2013", 
        "location": {
            "contact": {
                "email": "carmen.rebelatto@pucpr.br", 
                "last_name": "Carmen Rebelatto, PhD", 
                "phone": "+55 41 3271 1858"
            }, 
            "facility": {
                "address": {
                    "city": "Curitiba", 
                    "country": "Brazil", 
                    "state": "Paran\u00e1", 
                    "zip": "80215-901"
                }, 
                "name": "Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "1", 
        "official_title": "Multicentric Study of the Autologous Bone Marrow-derived Mononuclear Cells Injection for Treatment of the Patients With Critical Lower Extremity Ischemia", 
        "overall_contact": {
            "email": "paulo.brofman@pucpr.br", 
            "last_name": "Paulo Brofman, PhD", 
            "phone": "+55 41 3271 2219"
        }, 
        "overall_contact_backup": {
            "email": "alexandra.senegaglia@pucpr.br", 
            "last_name": "Alexandra Senegaglia, PhD", 
            "phone": "+55 41 3271 2219"
        }, 
        "overall_official": {
            "affiliation": "Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1", 
            "last_name": "Paulo Brofman, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Wound healing (wound size, wound stage) - monitoring the healing of trophic lesions", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01903044"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1", 
            "investigator_full_name": "Danielle Malheiros", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Improvement of symptoms, functional capacity, exercises tolerance assessed by change in Rutherford scale of CLI", 
                "measure": "Clinical outcome classification", 
                "safety_issue": "No", 
                "time_frame": "3 months, 6 months"
            }, 
            {
                "measure": "Pain and analgesics use", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Quality of life outcome", 
                "safety_issue": "No", 
                "time_frame": "3 months, 6 months"
            }, 
            {
                "measure": "Improvement of the coronary and collateral circulation.", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Survival without amputation", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Instituto de Mol\u00e9stias Cardiovasculares de S\u00e3o Jos\u00e9 do Rio Preto, Brazil", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Hospital Sao Rafael", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Hospital Geral Nacional Enrique Cabrera, Cuba", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Instituto de Hematolog\u00eda e Inmunolog\u00eda, Cuba", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Funda\u00e7\u00e3o Arauc\u00e1ria, Brazil", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}